87 related articles for article (PubMed ID: 29335388)
21. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
22. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
23. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
24. Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis.
Sampaio-Góes FC; Oliveira DT; Dorta RG; Nonogaki S; Landman G; Nishimoto IN; Kowalski LP
Head Neck; 2005 Nov; 27(11):982-9. PubMed ID: 16136583
[TBL] [Abstract][Full Text] [Related]
25. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
Nariai Y; Mishima K; Yoshimura Y; Sekine J
Int J Oral Maxillofac Surg; 2011 Apr; 40(4):419-26. PubMed ID: 21176871
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of HMGA2, P16, and HPV in oral squamous cell carcinomas.
Loeschke S; Ohlmann AK; Bräsen JH; Holst R; Warnke PH
J Craniomaxillofac Surg; 2016 Sep; 44(9):1422-9. PubMed ID: 27421171
[TBL] [Abstract][Full Text] [Related]
27. Expression of E-cadherin and involucrin in leukoplakia and oral cancer: an immunocytochemical and immunohistochemical study.
Silva AD; Maraschin BJ; Laureano NK; Daroit N; Brochier F; Bündrich L; Visioli F; Rados PV
Braz Oral Res; 2017 Mar; 31():e19. PubMed ID: 28273205
[TBL] [Abstract][Full Text] [Related]
28. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
[TBL] [Abstract][Full Text] [Related]
29. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
[TBL] [Abstract][Full Text] [Related]
30. Prognostic molecular markers in cancer - quo vadis?
Søland TM; Brusevold IJ
Histopathology; 2013 Sep; 63(3):297-308. PubMed ID: 23837466
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
32. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of oral squamous cell carcinoma: a tissue microarray study.
Solomon MC; Carnelio S; Gudattu V
Indian J Cancer; 2010; 47(2):166-72. PubMed ID: 20448381
[TBL] [Abstract][Full Text] [Related]
35. Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma.
Won HS; Jung CK; Chun SH; Kang JH; Kim YS; Sun DI; Kim MS
Oral Oncol; 2012 Oct; 48(10):985-990. PubMed ID: 22682934
[TBL] [Abstract][Full Text] [Related]
36. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
37. Expression of stem cell markers in oral cavity and oropharynx squamous cell carcinoma.
de Moraes FP; Lourenço SV; Ianez RC; de Sousa EA; Silva MM; Damascena AS; Kowalski LP; Soares FA; Coutinho-Camillo CM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jan; 123(1):113-122. PubMed ID: 27866975
[TBL] [Abstract][Full Text] [Related]
38. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B
Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of p53 and c-Myc at the invasive front of oral squamous cell carcinoma and its relation with clinicopathologic characteristics.
Rai P; Acharya S; Tayaar A; Kale J; Hallikeri K
Ann Diagn Pathol; 2017 Oct; 30():28-35. PubMed ID: 28965625
[No Abstract] [Full Text] [Related]
40. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
